Tuberculous meningitis in the elderly
Tuberculous meningitis, also known as tuberculous meningitis, is a non-purulent inflammation caused by the invasion of the meninges by Mycobacterium tuberculosis. It is part of systemic disseminated miliary tuberculosis and can also be secondary to bacteremia caused by tuberculous lesions in the lungs, lymph nodes, bones or urinary system. In addition, Mycobacterium tuberculosis can also directly break into the skull or spinal canal from tuberculous lesions in the skull or spine to cause tuberculous meningitis. Currently, more than half of the patients are adults. Cases have also been reported in the elderly. Three-quarters of adult tuberculous meningitis have adult primary lesions. The mortality rate of tuberculous meningitis is between 15% and 30%. If diagnosis and treatment are not timely, it can cause death or leave serious sequelae.
-
Site of disease:
Brain -
Infectious :
Contagious -
Frequent population:
aldult -
Related symptoms:
Fatigue Increased intracranial pressure Meningeal irritation Loss of appetite Low fever -
Concurrent disease:
Related Drugs
Rifampicin Tablets
Indication: 1 This product is used in combination with other anti-tuberculosis drugs for the initial and retreatment of various tuberculosis diseases, including the treatment of tuberculous meningitis. 2 This product is used in combination with other drugs to treat leprosy and non-tuberculous mycobacterial infections. 3 This product can be used in combination with vancomycin (intravenous) for severe infections caused by methicillin-resistant Staphylococci. The combination of rifampicin and erythromycin can be used for severe Legionella infections. 4 It is used for asymptomatic carriers of Neisseria meningitidis to eliminate Neisseria meningitidis in the nasopharynx; but it is not suitable for the treatment of Neisseria meningitidis infections.
Manufacturer:
Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
Related Ingredients